Encorium Group Hosting Its First Annual Healthcare Symposium: Impact, Prevention and Response to Pandemic Avian Flu.

Experts Examine Potential Crisis Waiting to Happen

WAYNE, Pa. -- Encorium Group, Inc. (Nasdaq: ENCO):

Speakers to Include:

* Dr. Christine Dumas, Medical and Health Care Reporter, NBC News and Fox News

"Critical Role of the Media in Saving Lives in the Event of Pandemic Avian Flu"

* Dr. Rick Bright, VP Global Influenza Programs, Novavax, Inc.

"The Potential Scope of the Healthcare Problem"

* Dr. W. Frank Peacock, Chairman of Emergency Preparedness and Director of Clinical Operations, Department of Emergency Medicine, Cleveland Clinic

"Lessons Learned from the Recent Pandemic Flu Drill Conducted at the Cleveland Clinic"

Encorium Group, Inc. (Nasdaq: ENCO), a leader in the design, development, and management of complex clinical trials and patient registries for many of the world's leading pharmaceutical and biotechnology companies announced today it will host its First Annual Healthcare Symposium on Wednesday, November 15, 2006. The topic will be "Impact, Prevention and Response to Pandemic Avian Flu: A Discussion with the Experts."

The Symposium will begin at 6:15 pm at The Radnor Hotel in St. Davids, PA, a venue in close proximity to Philadelphia. The program will be immediately preceded by a reception at 5:30 pm. The event will be hosted by Encorium's President and CEO, Kenneth M. Borow, M.D. in cooperation with the Healthy Living Channel.

Dr. Borow commented, "I agree with the conclusions from a recent report published by the Council on Foreign Relations (see link below), which stated that 'the probability of an avian influenza pandemic is high. When it occurs, its impact will potentially be severe in terms of loss of life, global economic disruption, social upheaval and political instability. This would be the first pandemic in the age of globalization. Its spread would be aided by international trade and travel and attempts to mitigate it will be hindered by breakdown in basic medical supplies and services.' It is clear that only with prevention and preparation are we as a society going to be able to cope with the challenges associated with this potential healthcare crisis. Our Symposium has been designed specifically to address the heart of these issues including the potential scope of the problem, the impact of Pandemic Avian Flu on emergency medical services, and the role of the media in conveying and interpreting information about this healthcare crisis and, in the process, saving lives."

The speakers at the event will include:

Dr. Christine Dumas is a medical reporter and author who has reported extensively on episodes of Avian Flu as they have occurred throughout the world. Since 1996, her stories have appeared on NBC News Today and NBC News Weekend Edition Today. Dr. Dumas appears regularly on Weekend Live on Fox News Channel. She has been a frequent guest on Tony Snow's nationally syndicated radio program where she comments on topical issues across medicine and health-related lifestyle choices. She has been featured on both Oprah and The View.

Dr. Rick Bright is an internationally recognized expert on influenza vaccine and antiviral research. He was formerly with the Centers for Disease Control and Prevention (CDC) and is a frequent advisor to the World Health Organization (WHO). Currently, Dr. Bright is Vice President of Global Influenza Programs at Novavax, Inc., a specialty biopharmaceutical company with an innovative technology platform for influenza and other viral illnesses.

Dr. W. Frank Peacock, Chairman of Emergency Preparedness and Director of Clinical Operations, Department of Emergency Medicine, Cleveland Clinic. Dr. Peacock was recently responsible for overseeing a Pandemic Flu Drill performed at the Cleveland Clinic, a simulation that resulted in eye-opening findings and messages for the future. Dr. Peacock is a nationally recognized authority on the impact of healthcare crises on Emergency Medical Services.

The event is free to senior executives in Pharmaceutical and Biotechnology Organizations, government, healthcare providers as well as community and business leaders. Those interested in attending the event must contact Marta Reis at 610-660-8720 or [e-mail], by Monday, November 13th to be added to the attendee list. For more information on the event, visitors are encouraged to visit www.encorium.com.

Those interested in reading the Council on Foreign Relations' summary on the "Global Threat of Pandemic Influenza," in its entirely, may do so by clicking the following link: http://www.cfr.org/content/publications/attachments/ pandemic_conference-summary.pdf.

(Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)

About Encorium Group, Inc.

Encorium Group, Inc. is a global clinical research organization that is a leader in the design and management of complex clinical trials and Patient Registries for the pharmaceutical, biotechnology and medical device industries. The Company's mission is to provide its clients with high quality, full-service support for their biopharmaceutical and medical device development programs. Encorium offers therapeutic expertise, experienced team management and advanced technologies. The Company has drug and biologics development as well as clinical trial experience across a wide variety of therapeutic areas such as cardiovascular, endocrinology/metabolism, diabetes, vaccines, infectious diseases, gene therapy, immunology, neurology, oncology, gastroenterology, dermatology, hepatology, women's health and respiratory medicine. Encorium believes that its leadership in the design of complex clinical trials, its therapeutic expertise and commitment to excellence, and its application of innovative technologies, offer its clients a means to more quickly and cost effectively move products through the clinical development process. Encorium is headquartered in Wayne, Pennsylvania with its European base of operations in Espoo, Finland. The Company has a geographic footprint that includes over one billion people in 25 countries in North America, Western/Central/Eastern Europe, Scandinavia, and the Baltics. In addition, Encorium Group, in collaboration with its Brazilian strategic partner, offers full-service CRO capabilities in South and Central America.

The Company provides operational services in 25 has more than 200 employees based in North America, Scandinavia, and throughout Europe with a direct geographic reach that covers 25 countries.

About the Healthy Living Channel

The Healthy Living Channel is one of 8 full time lifestyle transactional networks owned and operated by The Networks Group, a wholly owned subsidiary of The Media Group (TMG - formerly known as Turner Media Group). Healthy Living is the first channel of its kind to serve an audience actively in pursuit of wellness. The Healthy Living Channel combines content and commerce and is an interactive community for those seeking support, information, products and solutions through the most emotionally engaging and dynamic medium - the television. For more information, please visit the Healthy Living Channel's website at www.healthylivingtv.com.